One rising variant, BA.2.75.2, is particularly concerning for its potential to thwart the last monoclonal antibody left in the COVID arsenal: Bebtelovimab.
— Read on fortune.com/well/2022/09/22/new-covid-variants-subvariants-may-evade-treatments-eliminate-bebtelovimab-paxlovid-omicron-monoclonal-antibodies-vaccine-immune-evasion/
Categories
Pete's Library 